Cost of Revenue in USD of Fulgent Genetics, Inc. from 2014 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Fulgent Genetics, Inc. quarterly/annual Cost of Revenue history and change rate from 2014 to Q3 2025.
  • Fulgent Genetics, Inc. Cost of Revenue for the quarter ending 30 Sep 2025 was $48.6M, a 7.97% increase year-over-year.
  • Fulgent Genetics, Inc. Cost of Revenue for the twelve months ending 30 Sep 2025 was $185M, a 4.65% increase year-over-year.
  • Fulgent Genetics, Inc. annual Cost of Revenue for 2024 was $176M, a 4.6% decline from 2023.
  • Fulgent Genetics, Inc. annual Cost of Revenue for 2023 was $185M, a 26.7% decline from 2022.
  • Fulgent Genetics, Inc. annual Cost of Revenue for 2022 was $252M, a 17% increase from 2021.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Change (%)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Change (%)

Fulgent Genetics, Inc. Quarterly Cost of Revenue (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $185M $48.6M +$3.59M +7.97% 01 Jul 2025 30 Sep 2025 10-Q 07 Nov 2025
Q2 2025 $182M $47.4M +$2.83M +6.36% 01 Apr 2025 30 Jun 2025 10-Q 01 Aug 2025
Q1 2025 $179M $45.1M +$2.74M +6.46% 01 Jan 2025 31 Mar 2025 10-Q 02 May 2025
Q4 2024 $176M $44.4M -$911K -2.01% 01 Oct 2024 31 Dec 2024 10-K 28 Feb 2025
Q3 2024 $177M $45M +$129K +0.29% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2025
Q2 2024 $177M $44.5M -$2.74M -5.8% 01 Apr 2024 30 Jun 2024 10-Q 01 Aug 2025
Q1 2024 $180M $42.4M -$4.98M -10.5% 01 Jan 2024 31 Mar 2024 10-Q 02 May 2025
Q4 2023 $185M $45.3M -$9.44M -17.3% 01 Oct 2023 31 Dec 2023 10-K 28 Feb 2025
Q3 2023 $194M $44.8M -$14.7M -24.7% 01 Jul 2023 30 Sep 2023 10-Q 08 Nov 2024
Q2 2023 $209M $47.3M -$12.8M -21.3% 01 Apr 2023 30 Jun 2023 10-Q 02 Aug 2024
Q1 2023 $222M $47.4M -$30.4M -39.1% 01 Jan 2023 31 Mar 2023 10-Q 03 May 2024
Q4 2022 $252M $54.7M -$7.42M -11.9% 01 Oct 2022 31 Dec 2022 10-K 28 Feb 2023
Q3 2022 $259M $59.6M +$16.1M +37% 01 Jul 2022 30 Sep 2022 10-Q 03 Nov 2023
Q2 2022 $243M $60.1M +$24.2M +67.5% 01 Apr 2022 30 Jun 2022 10-Q 04 Aug 2023
Q1 2022 $219M $77.7M +$3.65M +4.93% 01 Jan 2022 31 Mar 2022 10-Q 05 May 2023
Q4 2021 $216M $62.1M +$10.4M +20% 01 Oct 2021 31 Dec 2021 10-K 28 Feb 2023
Q3 2021 $205M $43.5M +$17.2M +65.5% 01 Jul 2021 30 Sep 2021 10-K 28 Feb 2023
Q2 2021 $188M $35.9M +$28.1M +365% 01 Apr 2021 30 Jun 2021 10-K 28 Feb 2023
Q1 2021 $160M $74.1M +$70M +1726% 01 Jan 2021 31 Mar 2021 10-K 28 Feb 2023
Q4 2020 $89.8M $51.8M +$48.1M +1325% 01 Oct 2020 31 Dec 2020 10-K 28 Feb 2022
Q3 2020 $41.7M $26.3M +$22.4M +576% 01 Jul 2020 30 Sep 2020 10-K 28 Feb 2022
Q2 2020 $19.3M $7.72M +$4.1M +113% 01 Apr 2020 30 Jun 2020 10-K 28 Feb 2022
Q1 2020 $15.2M $4.06M +$1.09M +36.7% 01 Jan 2020 31 Mar 2020 10-K 28 Feb 2022
Q4 2019 $14.1M $3.63M +$865K +31.2% 01 Oct 2019 31 Dec 2019 10-K 08 Mar 2021
Q3 2019 $13.2M $3.89M +$1.27M +48.7% 01 Jul 2019 30 Sep 2019 10-K 08 Mar 2021
Q2 2019 $12M $3.62M +$1.08M +42.3% 01 Apr 2019 30 Jun 2019 10-K 08 Mar 2021
Q1 2019 $10.9M $2.97M +$196K +7.07% 01 Jan 2019 31 Mar 2019 10-K 08 Mar 2021
Q4 2018 $10.7M $2.77M +$224K +8.8% 01 Oct 2018 31 Dec 2018 10-K 13 Mar 2020
Q3 2018 $10.5M $2.61M +$344K +15.2% 01 Jul 2018 30 Sep 2018 10-K 13 Mar 2020
Q2 2018 $10.1M $2.54M +$665K +35.4% 01 Apr 2018 30 Jun 2018 10-K 13 Mar 2020
Q1 2018 $9.46M $2.77M +$913K +49.1% 01 Jan 2018 31 Mar 2018 10-K 13 Mar 2020
Q4 2017 $8.55M $2.55M +$682K +36.6% 01 Oct 2017 31 Dec 2017 10-K 22 Mar 2019
Q3 2017 $7.87M $2.27M +$125K +5.83% 01 Jul 2017 30 Sep 2017 10-K 22 Mar 2019
Q2 2017 $7.74M $1.88M +$468K +33.2% 01 Apr 2017 30 Jun 2017 10-K 22 Mar 2019
Q1 2017 $7.28M $1.86M +$555K +42.6% 01 Jan 2017 31 Mar 2017 10-K 22 Mar 2019
Q4 2016 $6.72M $1.86M -$863K -31.7% 01 Oct 2016 31 Dec 2016 10-K 20 Mar 2018
Q3 2016 $7.58M $2.14M +$1.23M +133% 01 Jul 2016 30 Sep 2016 10-K 20 Mar 2018
Q2 2016 $6.36M $1.41M +$639K +82.8% 01 Apr 2016 30 Jun 2016 10-K 20 Mar 2018
Q1 2016 $5.72M $1.3M +$651K +99.7% 01 Jan 2016 31 Mar 2016 10-K 20 Mar 2018
Q4 2015 $5.07M $2.73M 01 Oct 2015 31 Dec 2015 10-K 17 Mar 2017
Q3 2015 $918K 01 Jul 2015 30 Sep 2015 10-K 17 Mar 2017
Q2 2015 $772K 01 Apr 2015 30 Jun 2015 10-K 17 Mar 2017
Q1 2015 $653K 01 Jan 2015 31 Mar 2015 10-K 17 Mar 2017

Fulgent Genetics, Inc. Annual Cost of Revenue (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $176M -$8.5M -4.6% 01 Jan 2024 31 Dec 2024 10-K 28 Feb 2025
2023 $185M -$67.3M -26.7% 01 Jan 2023 31 Dec 2023 10-K 28 Feb 2025
2022 $252M +$36.5M +17% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2025
2021 $216M +$126M +140% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024
2020 $89.8M +$75.7M +537% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023
2019 $14.1M +$3.41M +31.9% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022
2018 $10.7M +$2.15M +25.1% 01 Jan 2018 31 Dec 2018 10-K 13 Mar 2020
2017 $8.55M +$1.83M +27.2% 01 Jan 2017 31 Dec 2017 10-K 22 Mar 2019
2016 $6.72M +$1.65M +32.6% 01 Jan 2016 31 Dec 2016 10-K 20 Mar 2018
2015 $5.07M +$4.13M +442% 01 Jan 2015 31 Dec 2015 10-K 17 Mar 2017
2014 $936K 01 Jan 2014 31 Dec 2014 10-K 17 Mar 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.